The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

The aim of this study was to investigate the dynamics of four of the most validated biomarkers for Alzheimer's disease (AD), cerebro-spinal fluid (CSF) Aβ 1-42, tau, hippocampal volume, and FDG-PET, in patients at different stage of AD. Two hundred twenty-nine cognitively healthy subjects, 154 mild cognitive impairment (MCI) patients converted to AD, and 193 (95 early and 98 late) AD patients were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. For each biomarker, individual values were Z-transformed and plotted against ADAS-cog scores, and sigmoid and linear fits were compared. For most biomarkers the sigmoid model fitted data significantly better than the linear model. Aβ 1-42 time course followed a steep curve, stabilizing early in the disease course. CSF tau and hippocampal volume changed later showing similar monotonous trends, reflecting disease progression. Hippocampal loss trend was steeper and occurred earlier in time in APOE ε4 carriers than in non-carriers. FDG-PET started changing early in time and likely followed a linear decline. In conclusion, this study provides the first evidence in favor of the dynamic biomarker model which has recently been proposed.

Original languageEnglish
Pages (from-to)1263-1274
Number of pages12
JournalNeurobiology of Aging
Volume31
Issue number8
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Neuroimaging
Alzheimer Disease
Biomarkers
Sigmoid Colon
Cerebrospinal Fluid
Disease Progression
Linear Models
Healthy Volunteers
Databases

Keywords

  • Alzheimer's disease
  • Alzheimer's Disease Neuroimaging Initiative dataset
  • Biomarker dynamics
  • Cerebro-spinal fluid Aβ 42
  • FDG-PET
  • Hippocampal volume
  • Tau

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Ageing
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

@article{673ff91b914a42fd8c6e3c606ce945d4,
title = "The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort",
abstract = "The aim of this study was to investigate the dynamics of four of the most validated biomarkers for Alzheimer's disease (AD), cerebro-spinal fluid (CSF) Aβ 1-42, tau, hippocampal volume, and FDG-PET, in patients at different stage of AD. Two hundred twenty-nine cognitively healthy subjects, 154 mild cognitive impairment (MCI) patients converted to AD, and 193 (95 early and 98 late) AD patients were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. For each biomarker, individual values were Z-transformed and plotted against ADAS-cog scores, and sigmoid and linear fits were compared. For most biomarkers the sigmoid model fitted data significantly better than the linear model. Aβ 1-42 time course followed a steep curve, stabilizing early in the disease course. CSF tau and hippocampal volume changed later showing similar monotonous trends, reflecting disease progression. Hippocampal loss trend was steeper and occurred earlier in time in APOE ε4 carriers than in non-carriers. FDG-PET started changing early in time and likely followed a linear decline. In conclusion, this study provides the first evidence in favor of the dynamic biomarker model which has recently been proposed.",
keywords = "Alzheimer's disease, Alzheimer's Disease Neuroimaging Initiative dataset, Biomarker dynamics, Cerebro-spinal fluid Aβ 42, FDG-PET, Hippocampal volume, Tau",
author = "A. Caroli and Frisoni, {G. B.}",
year = "2010",
month = "8",
doi = "10.1016/j.neurobiolaging.2010.04.024",
language = "English",
volume = "31",
pages = "1263--1274",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort

AU - Caroli, A.

AU - Frisoni, G. B.

PY - 2010/8

Y1 - 2010/8

N2 - The aim of this study was to investigate the dynamics of four of the most validated biomarkers for Alzheimer's disease (AD), cerebro-spinal fluid (CSF) Aβ 1-42, tau, hippocampal volume, and FDG-PET, in patients at different stage of AD. Two hundred twenty-nine cognitively healthy subjects, 154 mild cognitive impairment (MCI) patients converted to AD, and 193 (95 early and 98 late) AD patients were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. For each biomarker, individual values were Z-transformed and plotted against ADAS-cog scores, and sigmoid and linear fits were compared. For most biomarkers the sigmoid model fitted data significantly better than the linear model. Aβ 1-42 time course followed a steep curve, stabilizing early in the disease course. CSF tau and hippocampal volume changed later showing similar monotonous trends, reflecting disease progression. Hippocampal loss trend was steeper and occurred earlier in time in APOE ε4 carriers than in non-carriers. FDG-PET started changing early in time and likely followed a linear decline. In conclusion, this study provides the first evidence in favor of the dynamic biomarker model which has recently been proposed.

AB - The aim of this study was to investigate the dynamics of four of the most validated biomarkers for Alzheimer's disease (AD), cerebro-spinal fluid (CSF) Aβ 1-42, tau, hippocampal volume, and FDG-PET, in patients at different stage of AD. Two hundred twenty-nine cognitively healthy subjects, 154 mild cognitive impairment (MCI) patients converted to AD, and 193 (95 early and 98 late) AD patients were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. For each biomarker, individual values were Z-transformed and plotted against ADAS-cog scores, and sigmoid and linear fits were compared. For most biomarkers the sigmoid model fitted data significantly better than the linear model. Aβ 1-42 time course followed a steep curve, stabilizing early in the disease course. CSF tau and hippocampal volume changed later showing similar monotonous trends, reflecting disease progression. Hippocampal loss trend was steeper and occurred earlier in time in APOE ε4 carriers than in non-carriers. FDG-PET started changing early in time and likely followed a linear decline. In conclusion, this study provides the first evidence in favor of the dynamic biomarker model which has recently been proposed.

KW - Alzheimer's disease

KW - Alzheimer's Disease Neuroimaging Initiative dataset

KW - Biomarker dynamics

KW - Cerebro-spinal fluid Aβ 42

KW - FDG-PET

KW - Hippocampal volume

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=77954035720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954035720&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2010.04.024

DO - 10.1016/j.neurobiolaging.2010.04.024

M3 - Article

VL - 31

SP - 1263

EP - 1274

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -